Ann Van De Velde: Emerging Advances in Hemoglobinopathies, Sickle Cell Disease and Rare Anemias
Ann Van De Velde, President at Association Européenne des Illustrateurs Médicaux et Scientifiques (AEIMS), shared a post on LinkedIn:
“Preparing for the American Society of Hematology 2026 Online Meeting and selecting the key topics to follow and highlight in Red Blood Cell (RBC) medicine.
A good moment to revisit this publication with Tom Eyckmans Vanderfaeillie Anna and Philip Maes in the Belgian Journal of Hematology (BJH), the journal of the Belgian Hematology Society (BHS), and reflect on new developments, emerging evidence and clinical perspectives that deserved our attention at the European Hematology Association (EHA) Annual Meeting 2026 .
Looking back to move forward, with a particular focus on hemoglobinopathies and the evolving landscape of sickle cell disease and rare anaemias.”

See more in the gallery.
Stay updated with Hemostasis Today.
-
Nov 20, 2026, 06:29Markus Müller: ABO Blood Groups and the Rare Bombay Phenotype
-
Nov 20, 2026, 05:57Lance Reed: Specialized Blood Components and Clinical Samples for Research and Diagnostics
-
Nov 20, 2026, 05:41Sundas Anjum: Community Engagement and Blood Donation for Thalassemia Care
-
Nov 20, 2026, 05:24A Celebration of Unity and Dedication in Hemophilia Care – Hemophilia Society Mumbai Chapter
-
Nov 20, 2026, 05:09Farhad Sheikh: Prasugrel vs Ticagrelor in Acute Coronary Syndromes
-
Nov 20, 2026, 05:02Jason Acker: Appointed as the Next Editor-in-Chief of Vox Sanguinis
-
Nov 20, 2026, 04:58Sabri Kemahli: International Society of Hematology Celebrates 80 Years of Hematology with Special Webinar
-
Nov 20, 2026, 04:46Alessandra Bosch: Swiss Haemophilia Network Wins Research Grant
-
Nov 20, 2026, 04:41Courtney Lawrence: HLA Antibodies and Platelet Transfusion Refractoriness in Hispanic Patients